logo
An Observational, Retrospective Analysis of Retreatment with Bortezomib for Multiple Myeloma
Features and Risk Factors of Peripheral Neuropathy During Treatment with Bortezomib for Advanced Multiple Myeloma
Thalidomide Maintenance Following High-Dose Melphalan with Autologous Stem Cell Support in Myeloma
[18F]Fluorodeoxyglucose Positron Emission Tomography Scanning for Staging, Response Assessment, and Disease Surveillance in Patients with Mantle Cell Lymphoma
Cost-Effectiveness of Extended Adjuvant Rituximab for US Patients Aged 65-70 Years with Follicular Lymphoma in Second Remission
Promoter Hypermethylation of the MEG3 ( DLK1/MEG3 ) Imprinted Gene in Multiple Myeloma
Desensitization to Thalidomide in a Patient with Multiple Myeloma
Diffuse Large B-Cell Lymphoma Presenting as Multiple Lymphomatous Polyposis of the Gastrointestinal Tract
Successful Autologous Peripheral Blood Stem Cell Transplantation for a Patient with Primary Adrenal Lymphoma with Hemophagocytic Syndrome
Association Between Renal Cell Carcinoma and Plasma Cell Dyscrasias: A Case Series of Six Patients
A Case of Plasmacytoma of the Breast Mimicking an Inflammatory Carcinoma